ClinicalTrials.gg

Drug class

Histamine H2 Antagonists clinical trials

A class of medicines: the studies that test any of its 6 members, each study once. Members are as MeSH files each medicine’s actions, and as the NCI Thesaurus classes newer ones.

studies test it
99
open now
6
in phase 3
17
first study started
1996

Keep track of what changes. Save the histamine h2 antagonists studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Medicines in this class

Studies that test each. A study of two counts under both, and once above.

Lavoltidine
2

Studies by the year they started

96 studies that test it; most in 2006 (7)

Studies that test Histamine H2 Antagonists, by start year
YearStudies
19961
19981
20001
20022
20034
20043
20055
20067
20077
20083
20093
20102
20115
20125
20133
20144
20151
20161
20175
20185
20193
20206
20216
20222
20233
20243
20254
20261

By phase

A phase 1/2 study counts in both.

Phase 1
28
Phase 2
20
Phase 3
17
Phase 4
28
No phase
10

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 41 · Other 58

Dr. Reddy's Laboratories Limited (4) · Leidos Life Sciences (3) · Ruttonjee Hospital (3) · Emory University (3) · Boryung Pharmaceutical Co., Ltd (2) · Amgen (2) · University of Washington (2) · Boehringer Ingelheim (2)

Studies

Open first, then newest update. How each study uses a medicine is read from its arms, and is right about nine times in ten.

Testing one of them · 99

See all 99 studies that test one of the histamine h2 antagonists →